Financhill
Sell
34

ARMP Quote, Financials, Valuation and Earnings

Last price:
$1.43
Seasonality move :
2.29%
Day range:
$1.36 - $1.48
52-week range:
$0.90 - $3.45
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
520.90x
P/B ratio:
--
Volume:
15.1K
Avg. volume:
23.9K
1-year change:
-42.29%
Market cap:
$52M
Revenue:
--
EPS (TTM):
-$1.32

Earnings Data

Next earnings date for ARMP
May 07
2025
Most recent earnings per share
-$0.23
Beat by $0.12
(Mar 20/2025)
Consensus Estimate
-$0.35
(Mar 20/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ARMP Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $1.4M -- -- -$0.39 --
05/07/2025 Q1 $1.4M -- -- -$0.38 --
03/20/2025 Q4 $1.6M -- -$0.23 -$0.35 $0.12
11/13/2024 Q3 $900K -- -$0.15 -- --
08/13/2024 Q2 $1.1M -- -$0.25 -$0.36 $0.11
05/07/2024 Q1 $1.1M -- -$0.69 -$0.31 -$0.38
03/21/2024 Q4 $860K -- -$0.55 -$0.34 -$0.21
11/14/2023 Q3 -- -- -$0.86 -$0.31 -$0.55
08/14/2023 Q2 -- -- -$0.17 -$0.38 $0.21
05/11/2023 Q1 -- -- -$0.40 -$0.32 -$0.08
03/17/2023 Q4 -- -- -$0.29 -$0.28 -$0.01
11/09/2022 Q3 -- -- -$0.24 -$0.28 $0.04
08/11/2022 Q2 -- -- -$0.26 -$0.23 -$0.03
05/12/2022 Q1 -- -- -$0.30 -- --
03/18/2022 Q4 -- -- -$0.23 -- --
11/10/2021 Q3 -- -- -$0.22 -- --
08/12/2021 Q2 -- -- -$0.25 -- --
05/13/2021 Q1 -- -- -$0.27 -- --
03/18/2021 Q4 -- -- -$0.36 -- --
11/12/2020 Q3 -- -- -$0.31 -- --
08/13/2020 Q2 -- -- -$0.26 -- --
05/14/2020 Q1 -- -- -$0.49 -- --
03/19/2020 Q4 -- -- -$0.48 -- --
11/12/2019 Q3 -- -- -$0.73 -- --
08/14/2019 Q2 -- -- -$0.69 -- --
05/06/2019 Q1 -- -- -$0.80 -- --
12/31/2018 Q4 -- -- $1.51 -- --
09/30/2018 Q3 -- -- -$0.60 -- --
06/30/2018 Q2 -- -- -$2.66 -- --
03/31/2018 Q1 -- -- -$3.36 -- --
12/31/2017 Q4 -- -- -$0.56 -- --
09/30/2017 Q3 -- -- -$1.26 -- --
06/30/2017 Q2 -- -- -$20.44 -- --
03/31/2017 Q1 -- -- -$27.16 -- --
12/31/2016 Q4 -- -- -$106.40 -- --
09/30/2016 Q3 -- -- -$45.22 -- --
06/30/2016 Q2 -- -- -$109.48 -- --
03/31/2016 Q1 -- -- -$115.08 -- --
12/31/2015 Q4 -- -- -$75.60 -- --
09/30/2015 Q3 -- -- -$42.00 -- --
06/30/2015 Q2 -- -- $46.20 -- --

Armata Pharmaceuticals Earnings Questions

  • How Much did Armata Pharmaceuticals Generate in Revenue Last Quarter?

    Armata Pharmaceuticals reported -- worth of top line sales in its most recent quarter.

  • Did Armata Pharmaceuticals Beat Earnings Last Quarter?

    Armata Pharmaceuticals announced earnings per share of -$0.23 which represents a beat of analyst forecast a -$0.35 per share.

  • Is Armata Pharmaceuticals Profitable?

    Armata Pharmaceuticals reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Armata Pharmaceuticals EPS Next Year?

    Armata Pharmaceuticals's earnings are forecast to decrease from -$0.89 per share to -$0.95 per share next year representing a decrease of -117.98%.

  • When is Armata Pharmaceuticals's Earnings Date?

    Armata Pharmaceuticals's next earnings date is May 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Adobe Stock a Bargain With AI Tools Driving Growth?
Is Adobe Stock a Bargain With AI Tools Driving Growth?

The share price of American computer software company Adobe (NASDAQ:ADBE)…

Is Palantir Stock a Millionaire Maker?
Is Palantir Stock a Millionaire Maker?

Palantir (NASDAQ:PLTR) has shot upward over the last year and…

Is QuantumScape a Buy Now?
Is QuantumScape a Buy Now?

QuantumScape (NYSE:QS) is an innovative EV battery company that specializes…

Stock Ideas

Buy
71
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Sell
4
CABO alert for May 3

Cable One [CABO] is down 41.98% over the past day.

Buy
55
PDEX alert for May 3

Pro-Dex [PDEX] is down 32.02% over the past day.

Buy
91
TRUP alert for May 3

Trupanion [TRUP] is up 23.52% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock